7,10,13,16,19-docosapentaenoic acid

7,10,13,16,19-docosapentaenoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 1255 references associated with 7,10,13,16,19-docosapentaenoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 7,10,13,16,19-docosapentaenoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7,10,13,16,19-docosapentaenoic acid

MeSH term MeSH ID Detail
Chromosome Disorders D025063 4 associated lipids
Death, Sudden, Cardiac D016757 12 associated lipids
Atrial Fibrillation D001281 16 associated lipids
Heart Failure D006333 36 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Body Weight D001835 333 associated lipids
Total 10

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with 7,10,13,16,19-docosapentaenoic acid

Download all related citations
Per page 10 20 50 100 | Total 292
Authors Title Published Journal PubMed Link
Gregory MK and James MJ Functional characterization of the duck and turkey fatty acyl elongase enzymes ELOVL5 and ELOVL2. 2014 J. Nutr. pmid:24919687
Morin C et al. Docosapentaenoic acid monoacylglyceride reduces inflammation and vascular remodeling in experimental pulmonary hypertension. 2014 Am. J. Physiol. Heart Circ. Physiol. pmid:24929859
Leslie MA et al. Mammary tumour development is dose-dependently inhibited by n-3 polyunsaturated fatty acids in the MMTV-neu(ndl)-YD5 transgenic mouse model. 2014 Lipids Health Dis pmid:24916956
Wójcik C et al. Modulation of adipocyte differentiation by omega-3 polyunsaturated fatty acids involves the ubiquitin-proteasome system. 2014 J. Cell. Mol. Med. pmid:24834523
Grindel A et al. Cheek cell fatty acids reflect n-3 PUFA in blood fractions during linseed oil supplementation: a controlled human intervention study. 2013 Lipids Health Dis pmid:24229084
Kaur G et al. Orally administered [¹⁴C]DPA and [¹⁴C]DHA are metabolised differently to [¹⁴C]EPA in rats. 2013 Br. J. Nutr. pmid:22578196
Tu WC et al. Correlations between blood and tissue omega-3 LCPUFA status following dietary ALA intervention in rats. 2013 Prostaglandins Leukot. Essent. Fatty Acids pmid:22521090
Arm JP et al. Impact of botanical oils on polyunsaturated fatty acid metabolism and leukotriene generation in mild asthmatics. 2013 Lipids Health Dis pmid:24088297
Wu JH et al. Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial. 2013 J Am Heart Assoc pmid:24145742
Zimmer R et al. Effects of 1-year treatment with highly purified omega-3 fatty acids on depression after myocardial infarction: results from the OMEGA trial. 2013 J Clin Psychiatry pmid:24330904